These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 20464796

  • 21. Allopurinol: a necessary evil.
    Lim AY, Teng GG.
    Singapore Med J; 2009 Sep; 50(9):925-6; author reply 927. PubMed ID: 19787189
    [No Abstract] [Full Text] [Related]

  • 22. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E.
    Ugeskr Laeger; 1998 Feb 16; 160(8):1179-80. PubMed ID: 9492630
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia.
    Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-De la Villa F.
    BMJ; 2005 Sep 17; 331(7517):623-4. PubMed ID: 16166134
    [No Abstract] [Full Text] [Related]

  • 25. [Chronic gout. Case report of a severe course of disease].
    Boxberger F, Harsch IA, Brueckl WM, Hautmann M, Baum U, Hahn EG, Wein A.
    Med Klin (Munich); 2003 Nov 15; 98(11):646-7. PubMed ID: 14631540
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Fatal liver necrosis due to allopurinol].
    Pereira S, Almeida J, Silva AO, Quintas M, Candeias O, Freitas F.
    Acta Med Port; 1998 Dec 15; 11(12):1141-4. PubMed ID: 10192993
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
    Keenan RT, O'Brien WR, Lee KH, Crittenden DB, Fisher MC, Goldfarb DS, Krasnokutsky S, Oh C, Pillinger MH.
    Am J Med; 2011 Feb 15; 124(2):155-63. PubMed ID: 21295195
    [Abstract] [Full Text] [Related]

  • 29. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N, Stamp L.
    Semin Dial; 2007 Feb 15; 20(5):391-5. PubMed ID: 17897242
    [Abstract] [Full Text] [Related]

  • 30. Gout: joint pain and more.
    Harv Mens Health Watch; 2007 Dec 15; 12(5):1-3. PubMed ID: 18225332
    [No Abstract] [Full Text] [Related]

  • 31. Allopurinol induced generalized eosinophilic pustular folliculitis.
    Ooi CG, Walker P, Sidhu SK, Gordon LA, Marshman G.
    Australas J Dermatol; 2006 Nov 15; 47(4):270-3. PubMed ID: 17034470
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, Dalbeth N.
    Arthritis Rheum; 2012 Aug 15; 64(8):2529-36. PubMed ID: 22488501
    [Abstract] [Full Text] [Related]

  • 34. Allopurinol--dose according to effect, not renal function.
    Bryant L.
    J Prim Health Care; 2011 Dec 15; 3(4):323. PubMed ID: 22235497
    [No Abstract] [Full Text] [Related]

  • 35. Management of gout.
    Fox IH, Kelley WN.
    JAMA; 1979 Jul 27; 242(4):361-4. PubMed ID: 448944
    [No Abstract] [Full Text] [Related]

  • 36. [Early diagnosis and early treatment of gout].
    Mertz DP.
    Hippokrates; 1968 Jan 15; 39(1):5-12. PubMed ID: 5667616
    [No Abstract] [Full Text] [Related]

  • 37. Drug therapy reviews: pathogenesis and clinical management of hyperuricemia and gout.
    Mangini RJ.
    Am J Hosp Pharm; 1979 Apr 15; 36(4):497-504. PubMed ID: 433935
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [New drugs: allopurinol. Foligan, Urosin, Zyloric].
    Urologe A; 1974 Jan 15; 13(1):51. PubMed ID: 4824455
    [No Abstract] [Full Text] [Related]

  • 40. [Acute treatment of gout].
    Lund-Olesen K.
    Ugeskr Laeger; 1998 Mar 02; 160(10):1498. PubMed ID: 9520623
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.